{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:16:09Z","timestamp":1762078569749,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 P50 HL120163"],"award-info":[{"award-number":["1 P50 HL120163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN268201700001I","HHSN2682017000021","HHSN268201700003I","HHSN268201700004I","HHSN268201700005I"],"award-info":[{"award-number":["HHSN268201700001I","HHSN2682017000021","HHSN268201700003I","HHSN268201700004I","HHSN268201700005I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["P50"],"award-info":[{"award-number":["P50"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA"],"award-info":[{"award-number":["FDA"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.amjcard.2018.01.020","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T19:12:46Z","timestamp":1517944366000},"page":"1056-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study)"],"prefix":"10.1016","volume":"121","author":[{"given":"Martin","family":"Tibuakuu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Kianoush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"DeFilippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-5084","authenticated-orcid":false,"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.01.020_bib0010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/dar.12309","volume":"34","author":"Courtney","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0015","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Risk Factor Collaborators","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2017.01.021","article-title":"The relationship between smoking intensity and subclinical cardiovascular injury: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"258","author":"Al Rifai","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/ATVBAHA.114.304960","article-title":"Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"McEvoy","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0030","doi-asserted-by":"crossref","first-page":"dju294","DOI":"10.1093\/jnci\/dju294","article-title":"Cigarette smoking and variations in systemic immune and inflammation markers","volume":"106","author":"Shiels","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamainternmed.2016.7511","article-title":"Association of long-term low-intensity smoking with all-cause and cause-specific mortality in the NIH-AARP Diet and Health Study","volume":"177","author":"Inoue-Choi","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184914","article-title":"The association between cigarette smoking and inflammation: the Genetic Epidemiology Network of Arteriopathy (GENOA) study","volume":"12","author":"Tibuakuu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jclinepi.2016.09.010","article-title":"Smoking intensity (pack\/day) is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes","volume":"81","author":"Nance","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/ATVBAHA.116.308728","article-title":"Longitudinal impact of smoking and smoking cessation on inflammatory markers of cardiovascular disease risk","volume":"37","author":"King","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0055","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0060","article-title":"FDA clears test to help predict coronary heart disease risk","author":"Young","year":"2014","journal-title":"NEJM J Watch"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives","volume":"129","author":"The ARIC investigators","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0075","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.atherosclerosis.2006.02.016","article-title":"The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort","volume":"190","author":"Persson","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clinbiochem.2013.12.014","article-title":"High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum","volume":"47","author":"Doumatey","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCHEARTFAILURE.108.794933","article-title":"Absolute and attributable risks of heart failure incidence in relation to optimal risk factors","volume":"2","author":"Folsom","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.ATV.13.8.1139","article-title":"Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"13","author":"Brown","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","article-title":"Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions","volume":"55","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0895-4356(95)00041-0","article-title":"Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience","volume":"49","author":"White","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.30.4.736","article-title":"Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort","volume":"30","author":"Rosamond","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0110","first-page":"I1","article-title":"National Institute of Neurological and Communicative Disorders and Stroke","volume":"12","author":"The National Survey of Stroke","year":"1981","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0115","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ejhf.511","article-title":"Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"18","author":"Nadruz","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0135","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"Investigators","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0140","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","article-title":"Mortality in relation to smoking: 50 years' observations on male British doctors","volume":"328","author":"Doll","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2018.01.020_bib0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1211128","article-title":"21st-Century hazards of smoking and benefits of cessation in the United States","volume":"368","author":"Jha","year":"2013","journal-title":"N Engl J Med"},{"author":"Federal Register","key":"10.1016\/j.amjcard.2018.01.020_bib0150"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918301620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918301620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:12Z","timestamp":1762077852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918301620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0002914918301620"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}